BIONOMICS LIMITED - AM
0.3765
08-十一月-24 10:56:27
15 分钟延时
股票
-0.0035
-0.92%
今日范围
0.3402 - 0.3900
ISIN
N/A
来源
NASDAQ
-
Quarterly Activities and Cashflow Report
31 7月 2023 06:00:00 条件 Nasdaq GlobeNewswire
-
03 7月 2023 06:00:00 条件 Nasdaq GlobeNewswire
-
Bionomics to Present at Upcoming June Investor Conferences
15 6月 2023 08:00:01 条件 Nasdaq GlobeNewswire
-
30 5月 2023 06:00:00 条件 Nasdaq GlobeNewswire
-
Quarterly Activities and Cashflow Report
28 4月 2023 06:00:00 条件 Nasdaq GlobeNewswire
-
27 4月 2023 06:00:00 条件 Nasdaq GlobeNewswire
-
08 3月 2023 19:00:30 条件 Nasdaq GlobeNewswire
-
23 2月 2023 06:00:00 条件 Nasdaq GlobeNewswire
-
Quarterly Activities and Cashflow Report
30 1月 2023 18:23:46 条件 Nasdaq GlobeNewswire
-
Bionomics Reports Topline Results in PREVAIL Phase 2 Study of BNC210 in Social Anxiety Disorder
18 12月 2022 19:34:26 条件 Nasdaq GlobeNewswire
-
Bionomics appoints Spyridon “Spyros” Papapetropoulos as President and Chief Executive Officer
15 12月 2022 18:35:25 条件 Nasdaq GlobeNewswire
-
02 12月 2022 06:00:00 条件 Nasdaq GlobeNewswire
-
21 11月 2022 18:13:51 条件 Nasdaq GlobeNewswire
-
16 11月 2022 18:36:15 条件 Nasdaq GlobeNewswire
-
Bionomics Limited to Participate in Upcoming November Investor Conferences
02 11月 2022 06:00:00 条件 Nasdaq GlobeNewswire
-
Quarterly Activities Report for September 2022
25 10月 2022 06:00:00 条件 Nasdaq GlobeNewswire
-
Bionomics Receives R&D Tax Incentive Refund for FY2022 of A$4.6 million
18 10月 2022 06:00:00 条件 Nasdaq GlobeNewswire
-
Bionomics Limited to Participate in the Cantor Neurology & Psychiatry Conference
04 10月 2022 06:00:00 条件 Nasdaq GlobeNewswire
-
Bionomics to Host KOL Webinar on BNC210 and Social Anxiety Disorder
21 9月 2022 06:00:00 条件 Nasdaq GlobeNewswire